Human beta-defensin 1: a restless warrior against allergies, infections and cancer

Int J Biochem Cell Biol. 2010 Jun;42(6):800-4. doi: 10.1016/j.biocel.2010.01.021. Epub 2010 Jan 25.

Abstract

Human beta-defensin 1 (hBD-1) is probably the most important antimicrobial peptide in epithelial tissues. Its alleles and/or altered gene expression have been associated with at least 20 human diseases. hBD-1 is a tumor suppressor and DEFB1 is the only innate immunity gene that shows long-term balanced selection and heterozygote advantage. It is unique in its constitutive expression, but is still capable of upregulation upon inflammatory or microbial stimuli. The present minireview focuses on hBD-1 properties, biological function, its proposed pathogenic mechanisms and the potential uses of elicitors, inhibitors or the peptide itself in the treatment of hBD-1-related human diseases including allergies, infections and cancer.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Infective Agents / immunology
  • Anti-Infective Agents / metabolism*
  • Biomimetic Materials
  • Epithelium / metabolism
  • Genes, Tumor Suppressor
  • Genetic Predisposition to Disease
  • Humans
  • Hypersensitivity / genetics
  • Hypersensitivity / metabolism*
  • Hypersensitivity / therapy
  • Immunity, Innate
  • Immunomodulation
  • Infections / genetics
  • Infections / metabolism*
  • Infections / therapy
  • Neoplasms / genetics
  • Neoplasms / metabolism*
  • Neoplasms / therapy
  • Polymorphism, Genetic
  • beta-Defensins / genetics
  • beta-Defensins / immunology
  • beta-Defensins / metabolism*

Substances

  • Anti-Infective Agents
  • DEFB1 protein, human
  • beta-Defensins